William Walter Busse

17PUBLICATIONS
78CO-AUTHORS
Epidemiological modellingAdolescent healthEpigenetics (incl. genome methylation and epigenomics)PharmacogenomicsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 24, 2026
Real-World Effectiveness of Mepolizumab Initiation in Treating Asthma and Concurrent Chronic Obstructive Pulmonary Disease in the US.

|Sep 12, 2025
Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric Patients.

Yael A Leshem, Clara Weil, William W Busse

|Sep 02, 2025
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma.

Courtney L Gaberino, R Max Segnitz, Kimberly A Dill-McFarland

|Aug 06, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthma.

William W Busse, Monica Kraft, Christian Domingo

|Feb 18, 2025
The Direct and Indirect Role of IgE on Airway Epithelium in Asthma.

Christian Domingo, William W Busse, Nicola A Hanania

|Aug 19, 2024
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents.

So-Young Park, Stephen Fowler, Dominic E Shaw

Pageof 3

Frequent Collaborators

3 joint publications

Juby Anne Jacob-Nara

2 joint publications

Ian Douglas Pavord

2 joint publications

Oscar Palomares

2 joint publications

Nami Pandit-Abid